Loading...
VXRT VAXART INC Other Situations 8-K Filing
Back
VXRT
VXRT
VAXART INC
(VXRT)
Follow
FY2023 8 K
View More
Back
VXRT
VXRT
VAXART INC
(VXRT)
Follow
FY2023 8 K
Filing:
8 K
Published on:
6 Jun '23
Clinical Trials
28 Apr '25
Stock Offering
21 Mar '25
Financial Results
20 Mar '25
Vaccine Trial Announcement
11 Mar '25
Contract Halt
24 Feb '25
Funding Increase
10 Feb '25
Board Changes
28 Jan '25
Clinical Trial Update
21 Jan '25
Nasdaq Compliance Notice
31 Dec '24
Funding Increase
27 Dec '24
Vaccine Trial Update
4 Dec '24
Q3 Financial Results
13 Nov '24
Sales Agreement Termination
8 Oct '24
Funding Increase
30 Sep '24
Earnings Reports
8 Aug '24
Delisting
5 Jul '24
Amendment to Voting Results
20 Jun '24
Press Release
17 Jun '24
Underwriting Agreement
14 Jun '24
BARDA Funding Agreement
13 Jun '24
Amendment and Restatement o...
13 Jun '24
Earnings Reports
13 May '24
Clinical Trial Completion
30 Apr '24
Financial Results Announcement
14 Mar '24
Appointment of CEO
6 Mar '24
Management Changes
29 Feb '24
Compliance regained with Na...
15 Feb '24
Amendment - Separation Agre...
2 Feb '24
Delisting Notice
19 Jan '24
Securities Purchase Agreeme...
16 Jan '24
Contract Award and CEO Resi...
16 Jan '24
Financial Results Announcement
2 Nov '23
Disclosure of Say-on-Pay Vo...
23 Oct '23
Bylaws Amendment
23 Oct '23
Earnings Reports
3 Aug '23
Delisting Notice
26 Jul '23
Annual Meeting of Stockholders
28 Jun '23
Underwriting Agreement
8 Jun '23
Press Release Update
6 Jun '23
Compliance regained with Na...
25 May '23
Earnings Reports
9 May '23
Delisting
31 Mar '23
Earnings Reports
15 Mar '23
External Links:
SEC
AI Assistant
Close
VAXART INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.